BDMD — Baird Medical Investment Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- $89.95m
- $107.56m
- $37.04m
Annual cashflow statement for Baird Medical Investment Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 20-F |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | 12.8 | 10.7 | 12.6 |
| Depreciation | |||
| Deferred Taxes | |||
| Non-Cash Items | 0.434 | 2.34 | 1.25 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -14 | -14.9 | -21.7 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Change in Taxes Payable | |||
| Change in Other Liabilities | |||
| Cash from Operating Activities | 0.486 | -1.02 | -6.31 |
| Capital Expenditures | -5.95 | -2.64 | -2.85 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | 0.033 | 0 | — |
| Sale of Fixed Assets | |||
| Cash from Investing Activities | -5.92 | -2.64 | -2.85 |
| Financing Cash Flow Items | -0.046 | -1.01 | 0.408 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 4.41 | 3.46 | 10.7 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -1.32 | -0.2 | 1.46 |